Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rowe

Showing results (161-170 of 1,408) with videos related to

Pageof 141
Sort By:
Current Opinion in Hematology|January 10, 2012
Treatment for relapsed acute myeloid leukemia: what is new?Yishai Ofran, Jacob M Rowe
Leukemia|April 23, 2022
Cytogenetics or MRD in B-cell ALL. Do both reign supreme?Yishai Ofran, Jacob M Rowe
New York State Journal of Medicine|October 1, 1992
Pseudoleukemia in a patient with Hodgkin's diseaseS Mannheimer, J M Rowe
American Journal of Otolaryngology|December 5, 1998
Concepts for thyroid surgeryG H Petti, M Rowe
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|June 1, 1990
A retrospective study of 356 midfacial fractures occurring in 225 patientsH E Cook, M Rowe
Current Opinion in Hematology|December 27, 2018
Shifting therapeutic paradigms in induction and consolidation for older adults with acute myeloid leukemiaTsila Zuckerman, Jacob M Rowe
Current Opinion in Hematology|January 10, 2015
Introducing minimal residual disease in acute myeloid leukemiaYishai Ofran, Jacob M Rowe
Oncogene|November 15, 1997
Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activationJ E Floettmann, M Rowe
Haematologica|January 2, 2025
Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the CONSYishai Ofran, Jacob M Rowe
F1000Prime Reports|September 4, 2014
Pathogenesis and prognostication in acute lymphoblastic leukemiaTsila Zuckerman, Jacob M Rowe
Pageof 141

Showing results (161-170 of 1,408) with videos related to

Sort By:
Pageof 141
Current Opinion in Hematology|January 10, 2012
Treatment for relapsed acute myeloid leukemia: what is new?Yishai Ofran, Jacob M Rowe
Leukemia|April 23, 2022
Cytogenetics or MRD in B-cell ALL. Do both reign supreme?Yishai Ofran, Jacob M Rowe
New York State Journal of Medicine|October 1, 1992
Pseudoleukemia in a patient with Hodgkin's diseaseS Mannheimer, J M Rowe
American Journal of Otolaryngology|December 5, 1998
Concepts for thyroid surgeryG H Petti, M Rowe
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|June 1, 1990
A retrospective study of 356 midfacial fractures occurring in 225 patientsH E Cook, M Rowe
Current Opinion in Hematology|December 27, 2018
Shifting therapeutic paradigms in induction and consolidation for older adults with acute myeloid leukemiaTsila Zuckerman, Jacob M Rowe
Current Opinion in Hematology|January 10, 2015
Introducing minimal residual disease in acute myeloid leukemiaYishai Ofran, Jacob M Rowe
Oncogene|November 15, 1997
Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activationJ E Floettmann, M Rowe
Haematologica|January 2, 2025
Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the CONSYishai Ofran, Jacob M Rowe
F1000Prime Reports|September 4, 2014
Pathogenesis and prognostication in acute lymphoblastic leukemiaTsila Zuckerman, Jacob M Rowe
Pageof 141